Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioAtla Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$10.00 | -$10.00 | -$10.00 |
| Q2 2026 | 1 | -$8.50 | -$8.50 | -$8.50 |
| Q3 2026 | 1 | -$7.00 | -$7.00 | -$7.00 |
| Q4 2026 | 1 | -$7.00 | -$7.00 | -$7.00 |
BioAtla Inc Earnings Date And Information
BioAtla Inc last posted its earnings results on Thursday, August 13th, 2026. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $-8.5 by $8.77. The company had revenue of 6.50 M for the quarter and had revenue of 2.00 M for the year. BioAtla Inc has generated $-51 earnings per share over the last year ($-50.5 diluted earnings per share) and currently has a price-to-earnings ratio of -0.12. BioAtla Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
BioAtla Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2026 | Q2 2026 | -$8.50 | $0.27 | 8.77 | $6.50 M | $6.50 M |
| 05/15/2026 | Q1 2026 | -$10.00 | -$4.22 | 5.78 | $0 | $0 |
| 03/31/2026 | Q4 2025 | -$12.00 | -$8.00 | 4 | $700.00 K | $2.00 M |
| 11/13/2025 | Q3 2025 | -$0.31 | -$13.50 | -13.19 | N/A | $0 |
| 08/07/2025 | Q2 2025 | -$0.29 | -$16.00 | -15.71 | N/A | $0 |
| 05/06/2025 | Q1 2025 | -$0.29 | -$13.00 | -12.71 | N/A | $0 |
| 03/27/2025 | Q4 2024 | N/A | -$15.00 | N/A | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.36 | -$11.00 | -10.64 | N/A | $11.00 M |
| 08/08/2024 | Q2 2024 | N/A | -$22.00 | N/A | N/A | $0 |
| 05/14/2024 | Q1 2024 | -$0.79 | -$24.00 | -23.21 | N/A | $0 |
| 03/26/2024 | Q4 2023 | -$0.79 | -$28.00 | -27.21 | $15.00 M | $0 |
| 11/07/2023 | Q3 2023 | -$0.77 | -$35.00 | -34.23 | N/A | $0 |
| 08/01/2023 | Q2 2023 | -$0.64 | -$37.50 | -36.86 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.63 | -$27.50 | -26.87 | N/A | $0 |
| 03/23/2023 | Q4 2022 | -$0.73 | -$31.50 | -30.77 | $1.50 M | $0 |
| 11/04/2022 | Q3 2022 | -$0.80 | -$34.00 | -33.2 | $466.67 K | $0 |
| 08/09/2022 | Q2 2022 | -$0.69 | -$38.50 | -37.81 | $333.33 K | $0 |
| 05/05/2022 | Q1 2022 | -$0.69 | -$32.50 | -31.81 | $250.00 K | $0 |
| 02/28/2022 | Q4 2021 | N/A | -$34.50 | N/A | $4.60 M | $0 |
| 11/15/2021 | Q3 2021 | -$46.00 | -$34.00 | 12 | $10.98 M | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioAtla Inc Earnings: FAQ's
In the previous quarter, BioAtla Inc (:BCAB) reported $0.27 earnings per share (EPS) to beat the analysts' consensus estimate of $-8.5 by $8.77.
The conference call for BioAtla Inc's latest earnings report can be listened to online.
The conference call transcript for BioAtla Inc's latest earnings report can be read online.
BioAtla Inc (:BCAB) has a recorded annual revenue of $2.00 M.
BioAtla Inc (:BCAB) has a recorded net income of $-59,607,000.BioAtla Inc has generated $-50.5 earnings per share over the last four quarters.
BioAtla Inc (:BCAB) has a price-to-earnings ratio of -0.12 and price/earnings-to-growth ratio is -0.